219 related articles for article (PubMed ID: 30093656)
1. Dysregulation in Actin Cytoskeletal Organization Drives Increased Stiffness and Migratory Persistence in Polyploidal Giant Cancer Cells.
Xuan B; Ghosh D; Cheney EM; Clifton EM; Dawson MR
Sci Rep; 2018 Aug; 8(1):11935. PubMed ID: 30093656
[TBL] [Abstract][Full Text] [Related]
2. Vimentin filaments drive migratory persistence in polyploidal cancer cells.
Xuan B; Ghosh D; Jiang J; Shao R; Dawson MR
Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26756-26765. PubMed ID: 33046658
[TBL] [Abstract][Full Text] [Related]
3. Dedifferentiation into blastomere-like cancer stem cells via formation of polyploid giant cancer cells.
Niu N; Mercado-Uribe I; Liu J
Oncogene; 2017 Aug; 36(34):4887-4900. PubMed ID: 28436947
[TBL] [Abstract][Full Text] [Related]
4. Contributions of the distinct biophysical phenotype of polyploidal giant cancer cells to cancer progression.
Xuan B; Ghosh D; Dawson MR
Semin Cancer Biol; 2022 Jun; 81():64-72. PubMed ID: 33992783
[TBL] [Abstract][Full Text] [Related]
5. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.
Blanchard Z; Paul BT; Craft B; ElShamy WM
Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261
[TBL] [Abstract][Full Text] [Related]
6. Generation of Polyploid Giant Cancer Cells (PGCCs) from Hey Ovarian Cancer Cells and Analysis of Embryonic Properties.
Niu N; Liu J
Methods Mol Biol; 2024; 2825():281-292. PubMed ID: 38913316
[TBL] [Abstract][Full Text] [Related]
7. CoCl2, a mimic of hypoxia, induces formation of polyploid giant cells with stem characteristics in colon cancer.
Lopez-Sánchez LM; Jimenez C; Valverde A; Hernandez V; Peñarando J; Martinez A; Lopez-Pedrera C; Muñoz-Castañeda JR; De la Haba-Rodríguez JR; Aranda E; Rodriguez-Ariza A
PLoS One; 2014; 9(6):e99143. PubMed ID: 24932611
[TBL] [Abstract][Full Text] [Related]
8. Zhuidu Formula suppresses the migratory and invasive properties of triple-negative breast cancer cells via dual signaling pathways of RhoA/ROCK and CDC42/MRCK.
Wu Q; Ma X; Jin Z; Ni R; Pan Y; Yang G
J Ethnopharmacol; 2023 Oct; 315():116644. PubMed ID: 37196814
[TBL] [Abstract][Full Text] [Related]
9. Tumor stroma and differentiated cancer cells can be originated directly from polyploid giant cancer cells induced by paclitaxel.
Zhang S; Mercado-Uribe I; Liu J
Int J Cancer; 2014 Feb; 134(3):508-18. PubMed ID: 23754740
[TBL] [Abstract][Full Text] [Related]
10. Dormant cancer cells and polyploid giant cancer cells: The roots of cancer recurrence and metastasis.
Jiao Y; Yu Y; Zheng M; Yan M; Wang J; Zhang Y; Zhang S
Clin Transl Med; 2024 Feb; 14(2):e1567. PubMed ID: 38362620
[TBL] [Abstract][Full Text] [Related]
11. EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment.
Wang X; Zheng M; Fei F; Li C; Du J; Liu K; Li Y; Zhang S
Med Oncol; 2019 Aug; 36(9):82. PubMed ID: 31407170
[TBL] [Abstract][Full Text] [Related]
12. Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness.
Tilghman SL; Townley I; Zhong Q; Carriere PP; Zou J; Llopis SD; Preyan LC; Williams CC; Skripnikova E; Bratton MR; Zhang Q; Wang G
Mol Cell Proteomics; 2013 Sep; 12(9):2440-55. PubMed ID: 23704778
[TBL] [Abstract][Full Text] [Related]
13. A high expression ratio of RhoA/RhoB is associated with the migratory and invasive properties of basal-like Breast Tumors.
Privat M; Cavard A; Zekri Y; Ponelle-Chachuat F; Molnar I; Sonnier N; Bignon YJ
Int J Med Sci; 2020; 17(17):2799-2808. PubMed ID: 33162807
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of vimentin nuclear localization associated with the migration and invasion of daughter cells derived from polyploid giant cancer cells.
Fan L; Zheng M; Zhou X; Yu Y; Ning Y; Fu W; Xu J; Zhang S
J Transl Med; 2023 Oct; 21(1):719. PubMed ID: 37833712
[TBL] [Abstract][Full Text] [Related]
15. Polyploid Giant Cancer Cells (PGCCs): The Evil Roots of Cancer.
Chen J; Niu N; Zhang J; Qi L; Shen W; Donkena KV; Feng Z; Liu J
Curr Cancer Drug Targets; 2019; 19(5):360-367. PubMed ID: 29968537
[TBL] [Abstract][Full Text] [Related]
16. MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer.
Oudin MJ; Barbier L; Schäfer C; Kosciuk T; Miller MA; Han S; Jonas O; Lauffenburger DA; Gertler FB
Mol Cancer Ther; 2017 Jan; 16(1):143-155. PubMed ID: 27811011
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of Rho kinase (ROCK) signaling revert the malignant phenotype of breast cancer cells in 3D context.
Matsubara M; Bissell MJ
Oncotarget; 2016 May; 7(22):31602-22. PubMed ID: 27203208
[TBL] [Abstract][Full Text] [Related]
18. Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells.
Mukherjee P; Gupta A; Chattopadhyay D; Chatterji U
Sci Rep; 2017 Aug; 7(1):9170. PubMed ID: 28835684
[TBL] [Abstract][Full Text] [Related]
19. A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell line.
Lasham A; Mehta SY; Fitzgerald SJ; Woolley AG; Hearn JI; Hurley DG; Ruza I; Algie M; Shelling AN; Braithwaite AW; Print CG
Int J Cancer; 2016 Sep; 139(5):1157-70. PubMed ID: 27072400
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-22 promotes triple negative breast cancer cells migration and paclitaxel resistance through JAK-STAT3/MAPKs/AKT signaling pathways.
Wang S; Yao Y; Yao M; Fu P; Wang W
Biochem Biophys Res Commun; 2018 Sep; 503(3):1605-1609. PubMed ID: 30072097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
